ECM
TMO icon

Explore Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Explore Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,800
Closed -$5.72M – 16
2025
Q3 		$5.72M Sell
11,800
-200
-2% -$93.1K 3.54% 14
2025
Q2 		$4.87M Buy
+12,000
New +$5.02M 3.44% 12

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Explore Capital Management's TMO Position: Q4 2025 in Review

Explore Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 11,800 shares — an estimated $5.72M sold.

Explore Capital Management first reported a position in TMO in Q2 2025 and held it in 2 quarters. The position peaked at $5.72M in Q3 2025. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Explore Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • Explore Capital Management sold 11,800 Thermo Fisher Scientific shares in Q4 2025, an estimated $5.72M.
  • Explore Capital Management first reported a position in Thermo Fisher Scientific in Q2 2025 and held it in 2 quarters.
  • Explore Capital Management's Thermo Fisher Scientific position peaked at $5.72M in Q3 2025.
  • 2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Explore Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.